EMA - Meeting highlights from the Committee for Medicinal Products for Veterinary Use (CVMP) 10-12 May 2021

26th May 2021

CVMP opinions on veterinary medicinal products

The Committee adopted by consensus a positive opinion for a marketing authorisation application for Bonqat (pregabalin) from Orion Corporation, a new product for the alleviation of acute anxiety in cats.

The Committee adopted by consensus a positive opinion for a type II variation application for Simparica Trio concerning quality-related changes. The Committee also adopted by consensus a type IB variation grouped application (subject to a worksharing procedure) for Vectra 3D and Vectra Felis concerning quality-related changes.

View here

Back to News Archive